avrg: GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ELF2
|
ENSG00000109381.20 | ELF2 |
GABPA
|
ENSG00000154727.11 | GABPA |
ELF5
|
ENSG00000135374.11 | ELF5 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ELF2 | hg38_v1_chr4_-_139084289_139084496 | 0.43 | 3.2e-11 | Click! |
ELF5 | hg38_v1_chr11_-_34513785_34513805 | -0.33 | 7.9e-07 | Click! |
GABPA | hg38_v1_chr21_+_25734948_25734988 | 0.30 | 5.9e-06 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
95.5 | 286.4 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
92.0 | 275.9 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
84.7 | 508.2 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
69.0 | 207.1 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
68.9 | 206.7 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
61.6 | 246.5 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
51.0 | 255.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
49.8 | 149.5 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
48.5 | 194.1 | GO:0016334 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
47.5 | 47.5 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
47.3 | 142.0 | GO:0097212 | lysosomal membrane organization(GO:0097212) regulation of late endosome to lysosome transport(GO:1902822) |
45.7 | 137.2 | GO:0070476 | RNA (guanine-N7)-methylation(GO:0036265) rRNA (guanine-N7)-methylation(GO:0070476) |
45.6 | 227.8 | GO:0019348 | dolichol metabolic process(GO:0019348) |
45.2 | 316.6 | GO:1901315 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
44.8 | 134.3 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
43.9 | 131.8 | GO:0002188 | translation reinitiation(GO:0002188) |
43.6 | 130.9 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
43.6 | 87.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
41.9 | 251.6 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
40.7 | 122.0 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
40.5 | 162.2 | GO:0032240 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
40.5 | 161.9 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
40.4 | 121.3 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
40.2 | 120.7 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
39.5 | 158.2 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
39.3 | 39.3 | GO:0009838 | abscission(GO:0009838) |
38.6 | 308.5 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
38.1 | 38.1 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
37.9 | 37.9 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
37.6 | 150.5 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
37.0 | 148.1 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
36.4 | 109.3 | GO:1902524 | positive regulation of protein K48-linked ubiquitination(GO:1902524) |
35.7 | 178.4 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
35.4 | 106.1 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
35.0 | 210.0 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
34.7 | 104.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
34.6 | 241.9 | GO:0032218 | riboflavin transport(GO:0032218) |
34.1 | 102.4 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
33.2 | 232.7 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
32.3 | 97.0 | GO:1904732 | regulation of electron carrier activity(GO:1904732) |
32.1 | 32.1 | GO:0046070 | dGTP metabolic process(GO:0046070) |
31.8 | 222.7 | GO:0007144 | female meiosis I(GO:0007144) |
31.6 | 221.2 | GO:0006983 | ER overload response(GO:0006983) |
31.3 | 313.0 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
31.2 | 187.4 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
30.9 | 123.5 | GO:0002270 | plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) negative regulation of apoptotic cell clearance(GO:2000426) |
30.8 | 92.5 | GO:0071461 | cellular response to redox state(GO:0071461) |
30.7 | 92.0 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
30.3 | 91.0 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
30.2 | 181.4 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) |
29.3 | 117.3 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
28.4 | 170.2 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
27.7 | 194.0 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
27.5 | 110.1 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
27.4 | 109.7 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
27.2 | 1141.4 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
27.1 | 135.3 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
26.9 | 80.6 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
26.5 | 79.5 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
26.4 | 105.5 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
26.3 | 210.6 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
26.3 | 78.8 | GO:0097698 | telomere maintenance via base-excision repair(GO:0097698) |
25.9 | 77.6 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
25.6 | 128.0 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
25.6 | 25.6 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
25.6 | 128.0 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
25.4 | 101.4 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
24.9 | 2690.1 | GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) |
24.9 | 74.7 | GO:0016074 | snoRNA metabolic process(GO:0016074) |
24.6 | 271.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
24.3 | 194.4 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
24.2 | 24.2 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
24.1 | 120.6 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
24.0 | 673.1 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
23.9 | 95.5 | GO:0002084 | protein depalmitoylation(GO:0002084) |
23.6 | 70.8 | GO:0001188 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
23.6 | 165.2 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
23.5 | 234.9 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
23.0 | 506.5 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
22.5 | 67.6 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
22.4 | 112.0 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
22.3 | 155.8 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
22.2 | 111.1 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
21.8 | 65.5 | GO:0051182 | coenzyme transport(GO:0051182) |
21.5 | 301.0 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
21.5 | 64.4 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
21.4 | 42.8 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
21.2 | 42.4 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
20.5 | 451.2 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
20.5 | 102.4 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
20.4 | 142.9 | GO:0015866 | ADP transport(GO:0015866) |
20.3 | 223.0 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
20.1 | 80.4 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
20.1 | 140.6 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
20.0 | 621.5 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
19.9 | 59.6 | GO:0046081 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
19.7 | 59.1 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
19.6 | 58.8 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
19.3 | 57.9 | GO:1902568 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
19.2 | 134.5 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
19.1 | 38.3 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
18.8 | 56.5 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
18.7 | 56.2 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
18.7 | 56.2 | GO:0042946 | glucoside transport(GO:0042946) |
18.6 | 37.2 | GO:1903179 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
18.6 | 55.7 | GO:0036089 | cleavage furrow formation(GO:0036089) |
18.2 | 127.4 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
18.1 | 235.5 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
17.9 | 143.1 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
17.9 | 53.6 | GO:0014810 | positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014810) |
17.7 | 71.0 | GO:0039516 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
17.7 | 70.9 | GO:0043335 | protein unfolding(GO:0043335) |
17.7 | 53.1 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
17.6 | 52.8 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
17.6 | 70.3 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
17.4 | 69.8 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
17.4 | 104.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
17.2 | 137.9 | GO:1904851 | positive regulation of establishment of protein localization to telomere(GO:1904851) |
17.2 | 68.8 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
17.1 | 102.5 | GO:1900368 | adenosine to inosine editing(GO:0006382) regulation of RNA interference(GO:1900368) negative regulation of RNA interference(GO:1900369) |
16.8 | 84.2 | GO:0006740 | NADPH regeneration(GO:0006740) |
16.6 | 83.1 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
16.5 | 330.2 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
16.5 | 132.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
16.5 | 65.8 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
16.4 | 376.8 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
16.3 | 48.9 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
16.3 | 48.9 | GO:1902905 | positive regulation of fibril organization(GO:1902905) |
16.1 | 112.7 | GO:0015846 | polyamine transport(GO:0015846) |
16.1 | 16.1 | GO:0033206 | meiotic cytokinesis(GO:0033206) |
16.0 | 144.1 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
16.0 | 1150.7 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
16.0 | 63.9 | GO:0016240 | autophagosome docking(GO:0016240) |
15.9 | 47.7 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
15.9 | 31.8 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
15.8 | 142.5 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
15.7 | 31.4 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
15.7 | 344.9 | GO:0006293 | nucleotide-excision repair, preincision complex stabilization(GO:0006293) |
15.7 | 62.7 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
15.7 | 47.0 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
15.6 | 2000.6 | GO:0045047 | protein targeting to ER(GO:0045047) |
15.6 | 78.1 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
15.6 | 62.4 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
15.6 | 171.3 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
15.6 | 31.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
15.4 | 138.8 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
15.4 | 77.0 | GO:0030242 | pexophagy(GO:0030242) |
15.3 | 214.4 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
15.3 | 627.1 | GO:0009452 | 7-methylguanosine mRNA capping(GO:0006370) 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
15.3 | 122.1 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
15.2 | 259.0 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
15.1 | 45.2 | GO:0036388 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
15.0 | 165.3 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
14.9 | 59.6 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
14.9 | 89.3 | GO:0006696 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
14.8 | 29.7 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
14.7 | 44.0 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
14.6 | 131.7 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
14.6 | 58.5 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
14.6 | 160.6 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
14.4 | 201.7 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
14.4 | 71.9 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
14.4 | 86.3 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
14.2 | 42.5 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
14.1 | 70.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
14.1 | 28.2 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
13.9 | 13.9 | GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051439) |
13.9 | 554.6 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
13.8 | 55.2 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
13.7 | 109.8 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
13.6 | 136.3 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
13.6 | 54.3 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
13.5 | 54.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
13.5 | 67.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
13.5 | 53.9 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
13.5 | 80.8 | GO:0043248 | proteasome assembly(GO:0043248) |
13.4 | 67.1 | GO:0090135 | actin filament branching(GO:0090135) |
13.3 | 13.3 | GO:1902594 | viral penetration into host nucleus(GO:0075732) multi-organism nuclear import(GO:1902594) |
13.3 | 79.5 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
13.2 | 39.7 | GO:0070662 | mast cell proliferation(GO:0070662) |
13.2 | 13.2 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
13.2 | 289.3 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
13.1 | 118.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
13.1 | 91.6 | GO:0008215 | spermine metabolic process(GO:0008215) |
13.0 | 13.0 | GO:0019081 | viral translation(GO:0019081) |
13.0 | 64.8 | GO:0090168 | Golgi reassembly(GO:0090168) |
12.9 | 38.8 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
12.8 | 63.8 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
12.7 | 38.0 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
12.6 | 37.7 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
12.5 | 37.6 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
12.5 | 37.5 | GO:1901355 | response to rapamycin(GO:1901355) |
12.5 | 37.5 | GO:0070510 | regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
12.4 | 149.0 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
12.4 | 74.4 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
12.4 | 12.4 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) |
12.3 | 36.8 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
12.2 | 48.8 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
12.2 | 24.3 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
12.1 | 241.9 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
12.0 | 12.0 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
12.0 | 72.0 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
11.9 | 11.9 | GO:1903094 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
11.9 | 119.1 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
11.8 | 47.4 | GO:0018201 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) |
11.8 | 47.2 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
11.8 | 58.8 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
11.7 | 70.4 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
11.7 | 58.6 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
11.7 | 163.6 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
11.6 | 150.9 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
11.6 | 185.0 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
11.4 | 22.9 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
11.4 | 68.6 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
11.4 | 914.4 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
11.4 | 91.3 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
11.4 | 34.2 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
11.4 | 11.4 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
11.3 | 102.0 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
11.3 | 11.3 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
11.2 | 67.4 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
11.2 | 100.8 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
11.2 | 167.8 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
11.2 | 100.6 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
11.2 | 78.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
11.2 | 55.8 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
11.1 | 276.8 | GO:0006465 | signal peptide processing(GO:0006465) |
11.1 | 44.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
10.9 | 43.5 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
10.8 | 130.0 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
10.8 | 21.7 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
10.8 | 21.6 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
10.6 | 106.4 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
10.6 | 21.2 | GO:0009826 | unidimensional cell growth(GO:0009826) |
10.5 | 42.0 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
10.4 | 51.8 | GO:1904424 | regulation of GTP binding(GO:1904424) |
10.3 | 51.7 | GO:2001107 | negative regulation of establishment of T cell polarity(GO:1903904) negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
10.3 | 113.6 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
10.3 | 30.9 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
10.3 | 82.0 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
10.2 | 40.7 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
10.2 | 61.0 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
10.1 | 91.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
10.1 | 141.6 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
10.1 | 40.3 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
10.1 | 30.2 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
10.0 | 40.2 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
10.0 | 30.1 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
10.0 | 150.2 | GO:0016180 | snRNA processing(GO:0016180) |
10.0 | 29.9 | GO:0030047 | actin modification(GO:0030047) |
9.9 | 29.6 | GO:0030961 | peptidyl-arginine hydroxylation(GO:0030961) |
9.9 | 29.6 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
9.8 | 49.2 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
9.8 | 19.6 | GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) |
9.8 | 19.6 | GO:0045091 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
9.8 | 29.4 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
9.8 | 39.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
9.7 | 38.9 | GO:0002290 | gamma-delta T cell activation involved in immune response(GO:0002290) negative regulation of interferon-beta secretion(GO:0035548) regulation of gamma-delta T cell activation involved in immune response(GO:2001191) positive regulation of gamma-delta T cell activation involved in immune response(GO:2001193) |
9.7 | 38.7 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
9.7 | 29.0 | GO:0051793 | medium-chain fatty acid catabolic process(GO:0051793) |
9.6 | 28.8 | GO:2000174 | regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
9.6 | 57.5 | GO:0089700 | protein kinase D signaling(GO:0089700) |
9.5 | 161.9 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
9.5 | 95.0 | GO:0045116 | protein neddylation(GO:0045116) |
9.5 | 104.0 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
9.4 | 225.0 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
9.4 | 46.8 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
9.3 | 74.4 | GO:0045176 | apical protein localization(GO:0045176) |
9.3 | 27.8 | GO:1905216 | positive regulation of RNA binding(GO:1905216) |
9.3 | 656.9 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
9.2 | 46.2 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
9.1 | 128.0 | GO:0000338 | protein deneddylation(GO:0000338) |
9.1 | 18.1 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
9.0 | 45.2 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
9.0 | 180.9 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
9.0 | 27.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
9.0 | 36.0 | GO:0070433 | negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
9.0 | 18.0 | GO:0051177 | meiotic sister chromatid cohesion(GO:0051177) |
9.0 | 54.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
9.0 | 26.9 | GO:1901389 | regulation of transforming growth factor beta activation(GO:1901388) negative regulation of transforming growth factor beta activation(GO:1901389) |
8.9 | 35.8 | GO:0048200 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
8.9 | 44.6 | GO:0045337 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
8.9 | 8.9 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
8.8 | 114.5 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
8.8 | 131.8 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
8.8 | 26.3 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
8.8 | 52.6 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
8.8 | 26.3 | GO:0009106 | lipoate metabolic process(GO:0009106) |
8.7 | 69.8 | GO:0042407 | cristae formation(GO:0042407) |
8.7 | 43.5 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
8.7 | 43.4 | GO:0002176 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
8.6 | 43.0 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
8.5 | 17.1 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
8.5 | 663.3 | GO:0045454 | cell redox homeostasis(GO:0045454) |
8.5 | 280.5 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
8.5 | 59.4 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
8.5 | 42.3 | GO:1900086 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
8.4 | 25.3 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) |
8.4 | 33.7 | GO:1903182 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
8.4 | 16.8 | GO:0070269 | pyroptosis(GO:0070269) |
8.3 | 50.1 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
8.3 | 25.0 | GO:0006781 | succinyl-CoA pathway(GO:0006781) |
8.3 | 74.8 | GO:0006528 | asparagine metabolic process(GO:0006528) |
8.3 | 249.3 | GO:0006337 | nucleosome disassembly(GO:0006337) |
8.2 | 24.7 | GO:1904457 | glucosylceramide catabolic process(GO:0006680) beta-glucoside metabolic process(GO:1901804) beta-glucoside catabolic process(GO:1901805) positive regulation of neuronal action potential(GO:1904457) |
8.2 | 32.9 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
8.2 | 24.7 | GO:0035048 | splicing factor protein import into nucleus(GO:0035048) |
8.2 | 57.4 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
8.2 | 16.4 | GO:0009133 | ADP biosynthetic process(GO:0006172) nucleoside diphosphate biosynthetic process(GO:0009133) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
8.2 | 32.7 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
8.2 | 16.3 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
8.2 | 40.8 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
8.1 | 583.8 | GO:0048208 | vesicle coating(GO:0006901) vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
8.1 | 8.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
8.0 | 8.0 | GO:0032831 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
8.0 | 23.9 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
8.0 | 47.8 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
7.8 | 39.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
7.8 | 15.5 | GO:0010040 | response to iron(II) ion(GO:0010040) |
7.6 | 30.6 | GO:0043366 | beta selection(GO:0043366) |
7.6 | 22.9 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
7.6 | 38.1 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
7.6 | 53.3 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
7.6 | 68.5 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
7.6 | 30.4 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
7.6 | 22.8 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
7.6 | 22.8 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
7.6 | 68.1 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
7.5 | 60.0 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
7.5 | 37.5 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
7.5 | 59.9 | GO:0051026 | chiasma assembly(GO:0051026) |
7.4 | 14.9 | GO:0042255 | ribosome assembly(GO:0042255) |
7.4 | 118.9 | GO:0044818 | mitotic G2/M transition checkpoint(GO:0044818) |
7.3 | 95.1 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
7.3 | 21.9 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
7.3 | 72.8 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
7.3 | 36.3 | GO:1901838 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
7.2 | 231.9 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
7.2 | 94.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
7.2 | 35.9 | GO:0015862 | uridine transport(GO:0015862) |
7.2 | 79.0 | GO:0019388 | galactose catabolic process(GO:0019388) |
7.2 | 7.2 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
7.2 | 57.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
7.1 | 49.8 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
7.1 | 77.8 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
7.1 | 7.1 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
7.0 | 7.0 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
7.0 | 63.3 | GO:0070141 | response to UV-A(GO:0070141) cellular response to UV-A(GO:0071492) |
7.0 | 35.0 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
7.0 | 62.9 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
7.0 | 48.9 | GO:0072718 | response to cisplatin(GO:0072718) |
7.0 | 132.4 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
6.9 | 110.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
6.9 | 68.7 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
6.9 | 27.4 | GO:0034670 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
6.8 | 34.1 | GO:0070836 | caveola assembly(GO:0070836) |
6.8 | 40.7 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
6.8 | 202.7 | GO:0006625 | protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
6.7 | 6.7 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
6.7 | 26.7 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
6.6 | 86.4 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
6.6 | 19.9 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
6.6 | 79.3 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
6.6 | 26.4 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
6.5 | 13.1 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
6.5 | 437.9 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
6.5 | 32.6 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) positive regulation by virus of viral protein levels in host cell(GO:0046726) |
6.5 | 19.5 | GO:0038156 | interleukin-5-mediated signaling pathway(GO:0038043) interleukin-3-mediated signaling pathway(GO:0038156) |
6.5 | 64.8 | GO:0051601 | exocyst localization(GO:0051601) |
6.5 | 103.3 | GO:0006415 | translational termination(GO:0006415) |
6.4 | 32.2 | GO:2000035 | regulation of stem cell division(GO:2000035) |
6.4 | 32.2 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
6.4 | 38.4 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
6.4 | 19.1 | GO:0060544 | regulation of necroptotic process(GO:0060544) |
6.4 | 19.1 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
6.4 | 44.5 | GO:0032506 | cytokinetic process(GO:0032506) |
6.3 | 126.3 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
6.3 | 12.6 | GO:0031393 | negative regulation of prostaglandin biosynthetic process(GO:0031393) |
6.2 | 24.9 | GO:0090670 | RNA localization to Cajal body(GO:0090670) telomerase RNA localization to Cajal body(GO:0090671) telomerase RNA localization(GO:0090672) regulation of telomerase RNA localization to Cajal body(GO:1904872) |
6.2 | 18.6 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
6.2 | 18.6 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
6.2 | 12.4 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
6.2 | 24.7 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
6.2 | 18.5 | GO:0003162 | atrioventricular node development(GO:0003162) |
6.2 | 239.9 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
6.1 | 12.2 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
6.1 | 6.1 | GO:1901739 | regulation of myoblast fusion(GO:1901739) |
6.0 | 12.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
6.0 | 24.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
6.0 | 18.0 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
6.0 | 23.9 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
6.0 | 23.8 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
5.9 | 398.2 | GO:0006413 | translational initiation(GO:0006413) |
5.9 | 41.4 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
5.9 | 5.9 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
5.9 | 112.0 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
5.8 | 29.2 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
5.8 | 46.5 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
5.8 | 17.4 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
5.8 | 11.6 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
5.8 | 17.3 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
5.7 | 17.2 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
5.7 | 34.4 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
5.7 | 5.7 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
5.7 | 34.3 | GO:0039526 | suppression by virus of host apoptotic process(GO:0019050) modulation by virus of host apoptotic process(GO:0039526) |
5.6 | 39.4 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
5.6 | 16.8 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
5.6 | 151.3 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
5.6 | 95.2 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
5.6 | 72.8 | GO:0098969 | neurotransmitter receptor transport to plasma membrane(GO:0098877) neurotransmitter receptor transport to postsynaptic membrane(GO:0098969) establishment of protein localization to postsynaptic membrane(GO:1903540) |
5.6 | 16.8 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
5.6 | 50.3 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
5.6 | 1565.2 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
5.6 | 22.3 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
5.5 | 27.7 | GO:2000645 | regulation of receptor catabolic process(GO:2000644) negative regulation of receptor catabolic process(GO:2000645) |
5.5 | 160.4 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
5.5 | 16.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
5.5 | 21.8 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
5.4 | 37.9 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
5.4 | 48.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
5.4 | 32.2 | GO:0072553 | terminal button organization(GO:0072553) |
5.4 | 16.1 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
5.4 | 16.1 | GO:0036233 | glycine import(GO:0036233) |
5.3 | 101.6 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
5.3 | 26.7 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
5.3 | 53.3 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
5.3 | 21.3 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
5.3 | 16.0 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
5.3 | 21.3 | GO:0003409 | optic cup structural organization(GO:0003409) |
5.3 | 15.9 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
5.3 | 36.8 | GO:0051013 | microtubule severing(GO:0051013) |
5.2 | 5.2 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
5.2 | 57.1 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
5.2 | 10.4 | GO:0034769 | basement membrane disassembly(GO:0034769) |
5.2 | 5.2 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
5.1 | 20.5 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
5.1 | 10.2 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
5.1 | 25.5 | GO:0046618 | drug export(GO:0046618) |
5.1 | 10.2 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
5.1 | 15.2 | GO:2000798 | amniotic stem cell differentiation(GO:0097086) negative regulation of dense core granule biogenesis(GO:2000706) negative regulation of mesenchymal stem cell differentiation(GO:2000740) regulation of amniotic stem cell differentiation(GO:2000797) negative regulation of amniotic stem cell differentiation(GO:2000798) |
5.1 | 10.1 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
5.0 | 70.5 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
5.0 | 39.8 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
5.0 | 14.9 | GO:0071500 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) cellular response to nitrosative stress(GO:0071500) |
5.0 | 94.2 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
4.9 | 24.7 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
4.9 | 188.0 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
4.9 | 24.7 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
4.9 | 9.9 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
4.9 | 39.4 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
4.9 | 9.8 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
4.9 | 4.9 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
4.9 | 4.9 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
4.9 | 53.5 | GO:0006903 | vesicle targeting(GO:0006903) |
4.8 | 115.7 | GO:0016578 | histone deubiquitination(GO:0016578) |
4.8 | 38.5 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
4.8 | 9.6 | GO:0032632 | tolerance induction dependent upon immune response(GO:0002461) interleukin-3 production(GO:0032632) regulation of interleukin-3 production(GO:0032672) |
4.8 | 9.6 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
4.8 | 14.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
4.8 | 9.5 | GO:0035261 | external genitalia morphogenesis(GO:0035261) |
4.8 | 19.0 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
4.8 | 52.3 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
4.7 | 37.9 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
4.7 | 221.5 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
4.7 | 141.3 | GO:0090383 | phagosome acidification(GO:0090383) |
4.7 | 112.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
4.7 | 28.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
4.7 | 18.7 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
4.6 | 18.6 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
4.6 | 55.6 | GO:0014870 | response to muscle inactivity(GO:0014870) |
4.6 | 32.4 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
4.6 | 9.2 | GO:0031935 | regulation of chromatin silencing(GO:0031935) |
4.6 | 55.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
4.6 | 105.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
4.6 | 13.7 | GO:0070475 | rRNA base methylation(GO:0070475) |
4.5 | 9.1 | GO:1901253 | regulation of intracellular transport of viral material(GO:1901252) negative regulation of intracellular transport of viral material(GO:1901253) |
4.5 | 36.1 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
4.5 | 31.3 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
4.4 | 13.3 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
4.4 | 13.3 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
4.4 | 17.7 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
4.4 | 8.8 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
4.4 | 39.6 | GO:0001765 | membrane raft assembly(GO:0001765) |
4.4 | 30.7 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
4.4 | 13.1 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
4.4 | 21.8 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
4.4 | 113.2 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
4.3 | 12.9 | GO:0010768 | negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010768) transmission of virus(GO:0019089) dissemination or transmission of symbiont from host(GO:0044007) development involved in symbiotic interaction(GO:0044111) dissemination or transmission of organism from other organism involved in symbiotic interaction(GO:0051821) |
4.3 | 17.2 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
4.3 | 55.5 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
4.3 | 17.1 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
4.3 | 59.7 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
4.2 | 12.7 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
4.2 | 17.0 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
4.2 | 21.1 | GO:0044351 | macropinocytosis(GO:0044351) |
4.2 | 214.3 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
4.2 | 16.7 | GO:0007386 | compartment pattern specification(GO:0007386) |
4.2 | 8.4 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
4.1 | 29.0 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
4.1 | 37.1 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
4.1 | 65.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
4.1 | 16.3 | GO:0002357 | defense response to tumor cell(GO:0002357) |
4.1 | 16.3 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
4.1 | 36.6 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
4.1 | 12.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
4.1 | 28.4 | GO:0002254 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
4.0 | 52.5 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
4.0 | 383.1 | GO:0070527 | platelet aggregation(GO:0070527) |
4.0 | 32.3 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
4.0 | 44.2 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
4.0 | 12.0 | GO:0060613 | fat pad development(GO:0060613) |
4.0 | 23.8 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
4.0 | 43.6 | GO:0038203 | TORC2 signaling(GO:0038203) |
4.0 | 35.6 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
3.9 | 39.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
3.9 | 105.7 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
3.9 | 15.6 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
3.9 | 81.9 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
3.9 | 31.2 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
3.9 | 19.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
3.8 | 77.0 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
3.8 | 22.8 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
3.8 | 18.9 | GO:0071763 | nuclear membrane organization(GO:0071763) |
3.8 | 15.1 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
3.8 | 37.8 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
3.8 | 26.3 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
3.7 | 14.9 | GO:0009249 | protein lipoylation(GO:0009249) |
3.7 | 14.9 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
3.7 | 22.3 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
3.7 | 11.1 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
3.7 | 22.3 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
3.7 | 11.1 | GO:0018160 | peptidyl-pyrromethane cofactor linkage(GO:0018160) |
3.6 | 18.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
3.6 | 7.2 | GO:1902741 | interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
3.6 | 107.5 | GO:0070207 | protein homotrimerization(GO:0070207) |
3.6 | 14.3 | GO:0016139 | glycoside catabolic process(GO:0016139) |
3.6 | 28.6 | GO:1903027 | regulation of opsonization(GO:1903027) |
3.6 | 35.6 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
3.5 | 53.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
3.5 | 21.2 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
3.5 | 204.6 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
3.5 | 17.5 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
3.5 | 38.5 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
3.5 | 10.5 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
3.5 | 3.5 | GO:1904587 | response to glycoprotein(GO:1904587) |
3.5 | 3.5 | GO:1902566 | regulation of eosinophil activation(GO:1902566) |
3.5 | 17.3 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
3.5 | 17.3 | GO:0051014 | actin filament severing(GO:0051014) |
3.5 | 6.9 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
3.4 | 13.8 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
3.4 | 44.4 | GO:0007172 | signal complex assembly(GO:0007172) |
3.4 | 3.4 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
3.4 | 142.3 | GO:0051642 | centrosome localization(GO:0051642) |
3.4 | 61.0 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
3.4 | 3.4 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of lipoprotein particle clearance(GO:0010986) |
3.4 | 33.6 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
3.4 | 30.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
3.4 | 161.3 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
3.4 | 26.8 | GO:0070543 | response to linoleic acid(GO:0070543) blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
3.4 | 20.1 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
3.3 | 23.4 | GO:1903541 | regulation of exosomal secretion(GO:1903541) |
3.3 | 13.3 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
3.3 | 16.6 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
3.3 | 9.9 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
3.3 | 66.1 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
3.3 | 3.3 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
3.3 | 19.7 | GO:1902969 | mitotic DNA replication(GO:1902969) |
3.3 | 29.5 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
3.3 | 9.8 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
3.3 | 3.3 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
3.3 | 29.4 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
3.3 | 13.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
3.3 | 153.4 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
3.3 | 32.5 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
3.2 | 55.2 | GO:2000758 | positive regulation of histone acetylation(GO:0035066) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
3.2 | 9.7 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
3.2 | 99.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
3.2 | 12.8 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
3.2 | 3.2 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
3.2 | 41.6 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
3.2 | 3.2 | GO:0001302 | replicative cell aging(GO:0001302) |
3.2 | 16.0 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
3.2 | 16.0 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
3.2 | 28.7 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
3.2 | 3.2 | GO:0097264 | self proteolysis(GO:0097264) |
3.2 | 9.5 | GO:0032759 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
3.2 | 3.2 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) |
3.2 | 25.3 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
3.2 | 28.4 | GO:0060056 | mammary gland involution(GO:0060056) |
3.1 | 6.3 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
3.1 | 6.3 | GO:1904117 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
3.1 | 18.8 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
3.1 | 28.0 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
3.1 | 21.7 | GO:0045793 | positive regulation of cell size(GO:0045793) |
3.1 | 18.4 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
3.1 | 24.5 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
3.1 | 3.1 | GO:1903911 | positive regulation of postsynaptic membrane organization(GO:1901628) positive regulation of receptor clustering(GO:1903911) |
3.1 | 33.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
3.0 | 3.0 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
3.0 | 3.0 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
3.0 | 9.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
3.0 | 15.1 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
3.0 | 3.0 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
3.0 | 9.0 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
3.0 | 17.9 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
3.0 | 8.9 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
3.0 | 17.8 | GO:0009597 | detection of virus(GO:0009597) |
3.0 | 3.0 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
3.0 | 8.9 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
3.0 | 8.9 | GO:1903301 | positive regulation of hexokinase activity(GO:1903301) |
2.9 | 2.9 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
2.9 | 63.4 | GO:0030042 | actin filament depolymerization(GO:0030042) |
2.9 | 2.9 | GO:0051884 | regulation of anagen(GO:0051884) |
2.8 | 70.5 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
2.8 | 5.6 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
2.8 | 11.2 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
2.8 | 22.4 | GO:0002934 | desmosome organization(GO:0002934) |
2.8 | 42.0 | GO:0035855 | megakaryocyte development(GO:0035855) |
2.8 | 39.1 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
2.8 | 8.4 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
2.8 | 105.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
2.8 | 27.7 | GO:0051290 | protein heterotetramerization(GO:0051290) |
2.8 | 159.6 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
2.8 | 5.5 | GO:0090234 | regulation of centromere complex assembly(GO:0090230) regulation of kinetochore assembly(GO:0090234) |
2.7 | 178.4 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
2.7 | 10.9 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
2.7 | 24.5 | GO:0006089 | lactate metabolic process(GO:0006089) |
2.7 | 24.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
2.7 | 19.0 | GO:0030421 | defecation(GO:0030421) |
2.7 | 16.3 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
2.7 | 43.4 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
2.7 | 8.1 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
2.7 | 18.9 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
2.7 | 48.6 | GO:0006491 | N-glycan processing(GO:0006491) |
2.7 | 16.2 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
2.7 | 24.2 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
2.7 | 18.8 | GO:0007619 | courtship behavior(GO:0007619) |
2.7 | 18.8 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
2.6 | 123.7 | GO:0043171 | peptide catabolic process(GO:0043171) |
2.6 | 13.0 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
2.6 | 10.4 | GO:0061643 | chemorepulsion of dopaminergic neuron axon(GO:0036518) chemorepulsion of axon(GO:0061643) |
2.6 | 7.8 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
2.6 | 7.8 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
2.6 | 76.7 | GO:0006611 | protein export from nucleus(GO:0006611) |
2.5 | 5.1 | GO:0043323 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
2.5 | 10.1 | GO:0042631 | cellular response to water deprivation(GO:0042631) cellular response to water stimulus(GO:0071462) |
2.5 | 38.0 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
2.5 | 55.1 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
2.5 | 25.0 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
2.5 | 37.4 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
2.5 | 5.0 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
2.5 | 17.3 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
2.5 | 4.9 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
2.4 | 68.6 | GO:0061641 | chromatin remodeling at centromere(GO:0031055) CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
2.4 | 31.7 | GO:0007220 | Notch receptor processing(GO:0007220) |
2.4 | 7.3 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
2.4 | 120.6 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
2.4 | 7.2 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
2.4 | 9.6 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
2.4 | 35.9 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
2.4 | 2.4 | GO:0001927 | exocyst assembly(GO:0001927) |
2.4 | 7.1 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
2.4 | 2.4 | GO:0048378 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) |
2.3 | 4.7 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
2.3 | 11.7 | GO:0034127 | regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034127) negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
2.3 | 30.4 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
2.3 | 11.7 | GO:1903299 | regulation of hexokinase activity(GO:1903299) |
2.3 | 7.0 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
2.3 | 2.3 | GO:0007343 | egg activation(GO:0007343) |
2.3 | 32.5 | GO:0021670 | lateral ventricle development(GO:0021670) |
2.3 | 7.0 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
2.3 | 6.9 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
2.3 | 13.7 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
2.3 | 15.9 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
2.3 | 13.6 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
2.3 | 4.5 | GO:0006196 | AMP catabolic process(GO:0006196) |
2.3 | 11.3 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
2.2 | 9.0 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
2.2 | 20.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
2.2 | 6.7 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
2.2 | 35.6 | GO:0018345 | protein palmitoylation(GO:0018345) |
2.2 | 8.9 | GO:0043382 | regulation of memory T cell differentiation(GO:0043380) positive regulation of memory T cell differentiation(GO:0043382) |
2.2 | 41.6 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
2.2 | 6.6 | GO:0002384 | hepatic immune response(GO:0002384) |
2.2 | 10.9 | GO:0015793 | glycerol transport(GO:0015793) |
2.2 | 58.4 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
2.2 | 4.3 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
2.2 | 28.0 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
2.2 | 8.6 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
2.1 | 15.0 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
2.1 | 8.5 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
2.1 | 6.4 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
2.1 | 6.4 | GO:0006642 | triglyceride mobilization(GO:0006642) |
2.1 | 6.4 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
2.1 | 4.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
2.1 | 67.5 | GO:0006414 | translational elongation(GO:0006414) |
2.1 | 4.2 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
2.1 | 6.3 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
2.1 | 12.6 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
2.1 | 27.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
2.1 | 22.9 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
2.1 | 20.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
2.1 | 2.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
2.1 | 8.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
2.0 | 10.2 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
2.0 | 8.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
2.0 | 6.0 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
2.0 | 306.8 | GO:0008360 | regulation of cell shape(GO:0008360) |
2.0 | 12.0 | GO:0042761 | fatty acid elongation(GO:0030497) very long-chain fatty acid biosynthetic process(GO:0042761) |
2.0 | 9.9 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
2.0 | 9.9 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
2.0 | 17.8 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
2.0 | 3.9 | GO:0061009 | common bile duct development(GO:0061009) |
1.9 | 13.5 | GO:0035897 | proteolysis in other organism(GO:0035897) |
1.9 | 42.4 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
1.9 | 21.0 | GO:0006552 | leucine catabolic process(GO:0006552) |
1.9 | 3.8 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
1.9 | 7.6 | GO:0000212 | meiotic spindle organization(GO:0000212) |
1.9 | 20.9 | GO:0070206 | protein trimerization(GO:0070206) |
1.9 | 5.7 | GO:0060957 | endocardial cell fate commitment(GO:0060957) endocardial cushion cell differentiation(GO:0061443) endocardial cushion cell fate commitment(GO:0061445) positive regulation of determination of dorsal identity(GO:2000017) |
1.9 | 9.4 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
1.9 | 3.8 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) |
1.9 | 11.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
1.9 | 13.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
1.9 | 7.5 | GO:0090009 | primitive streak formation(GO:0090009) |
1.9 | 9.3 | GO:0002347 | response to tumor cell(GO:0002347) |
1.8 | 16.5 | GO:0097320 | membrane tubulation(GO:0097320) |
1.8 | 1.8 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
1.8 | 12.7 | GO:0036010 | protein localization to endosome(GO:0036010) |
1.8 | 3.6 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
1.8 | 12.5 | GO:0035456 | response to interferon-beta(GO:0035456) |
1.8 | 3.6 | GO:0021569 | rhombomere 3 development(GO:0021569) |
1.8 | 44.2 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
1.7 | 12.2 | GO:0006116 | NADH oxidation(GO:0006116) |
1.7 | 10.4 | GO:0038092 | nodal signaling pathway(GO:0038092) |
1.7 | 1.7 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
1.7 | 12.0 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
1.7 | 1.7 | GO:0060066 | oviduct development(GO:0060066) |
1.7 | 5.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.7 | 3.4 | GO:0006059 | hexitol metabolic process(GO:0006059) |
1.7 | 61.2 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
1.7 | 3.4 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
1.7 | 5.1 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
1.7 | 8.3 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
1.6 | 11.5 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
1.6 | 1.6 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
1.6 | 9.9 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
1.6 | 13.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
1.6 | 13.0 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
1.6 | 3.2 | GO:1902463 | establishment of Sertoli cell barrier(GO:0097368) protein localization to cell leading edge(GO:1902463) |
1.6 | 11.2 | GO:0030091 | protein repair(GO:0030091) |
1.6 | 3.2 | GO:0070384 | Harderian gland development(GO:0070384) |
1.6 | 30.2 | GO:0006513 | protein monoubiquitination(GO:0006513) |
1.6 | 99.5 | GO:0034728 | nucleosome organization(GO:0034728) |
1.6 | 11.0 | GO:0021903 | rostrocaudal neural tube patterning(GO:0021903) |
1.6 | 44.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.6 | 4.7 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
1.6 | 17.1 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
1.5 | 4.6 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
1.5 | 9.1 | GO:0031639 | plasminogen activation(GO:0031639) |
1.5 | 9.1 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
1.5 | 1.5 | GO:2000566 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
1.5 | 4.5 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
1.5 | 7.4 | GO:0001880 | Mullerian duct regression(GO:0001880) |
1.5 | 17.8 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
1.5 | 4.4 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
1.5 | 1.5 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
1.5 | 5.8 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
1.4 | 4.3 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
1.4 | 7.1 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
1.4 | 39.6 | GO:0061640 | cytoskeleton-dependent cytokinesis(GO:0061640) |
1.4 | 4.2 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
1.4 | 12.7 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
1.4 | 9.6 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
1.4 | 11.0 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
1.4 | 2.7 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
1.3 | 20.2 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
1.3 | 170.8 | GO:0006457 | protein folding(GO:0006457) |
1.3 | 3.9 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
1.3 | 14.3 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
1.3 | 2.6 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
1.3 | 15.2 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
1.3 | 7.6 | GO:0034205 | beta-amyloid formation(GO:0034205) |
1.3 | 3.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.3 | 41.4 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
1.2 | 5.0 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
1.2 | 3.7 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
1.2 | 3.7 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
1.2 | 7.4 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
1.2 | 7.3 | GO:0000012 | single strand break repair(GO:0000012) |
1.2 | 7.3 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
1.2 | 6.1 | GO:0033227 | dsRNA transport(GO:0033227) |
1.2 | 4.8 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
1.2 | 20.5 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
1.2 | 1.2 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
1.2 | 82.5 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
1.2 | 1.2 | GO:0050904 | diapedesis(GO:0050904) |
1.2 | 4.8 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
1.2 | 4.7 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
1.2 | 5.9 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
1.2 | 9.5 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
1.2 | 8.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
1.2 | 8.3 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
1.2 | 5.9 | GO:0006551 | leucine metabolic process(GO:0006551) branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
1.2 | 25.8 | GO:0006270 | DNA replication initiation(GO:0006270) |
1.2 | 16.3 | GO:0090224 | regulation of spindle organization(GO:0090224) |
1.2 | 11.6 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
1.2 | 4.6 | GO:0040016 | embryonic cleavage(GO:0040016) |
1.2 | 57.8 | GO:0051289 | protein homotetramerization(GO:0051289) |
1.1 | 59.4 | GO:0006364 | rRNA processing(GO:0006364) |
1.1 | 20.5 | GO:0044804 | nucleophagy(GO:0044804) |
1.1 | 3.4 | GO:0035995 | detection of muscle stretch(GO:0035995) |
1.1 | 1.1 | GO:1905069 | negative regulation of mononuclear cell migration(GO:0071676) allantois development(GO:1905069) |
1.1 | 5.6 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
1.1 | 5.6 | GO:0046449 | creatinine metabolic process(GO:0046449) |
1.1 | 23.3 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
1.1 | 6.6 | GO:0015886 | heme transport(GO:0015886) |
1.1 | 34.1 | GO:0008210 | estrogen metabolic process(GO:0008210) |
1.1 | 14.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
1.1 | 2.2 | GO:0002711 | positive regulation of T cell mediated immunity(GO:0002711) |
1.1 | 373.0 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
1.1 | 4.3 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
1.1 | 30.7 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
1.1 | 2.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
1.1 | 3.2 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
1.1 | 53.6 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
1.1 | 82.0 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
1.0 | 18.2 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
1.0 | 5.1 | GO:0006573 | valine metabolic process(GO:0006573) |
1.0 | 5.0 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
1.0 | 24.1 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
1.0 | 4.0 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
1.0 | 27.7 | GO:0015893 | drug transport(GO:0015893) |
1.0 | 7.9 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
1.0 | 3.8 | GO:0051352 | negative regulation of ligase activity(GO:0051352) |
1.0 | 13.4 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
1.0 | 1.9 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
1.0 | 17.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.9 | 1.9 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.9 | 8.4 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.9 | 1.8 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.9 | 8.1 | GO:0051383 | kinetochore organization(GO:0051383) |
0.9 | 2.7 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.9 | 1.8 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.9 | 3.5 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.9 | 0.9 | GO:0006771 | riboflavin metabolic process(GO:0006771) flavin-containing compound metabolic process(GO:0042726) |
0.9 | 5.1 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.9 | 4.3 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.9 | 11.9 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.8 | 10.1 | GO:0097502 | mannosylation(GO:0097502) |
0.8 | 2.5 | GO:2001045 | closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.8 | 2.5 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
0.8 | 70.4 | GO:0002576 | platelet degranulation(GO:0002576) |
0.8 | 4.9 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.8 | 1.6 | GO:0010677 | negative regulation of cellular carbohydrate metabolic process(GO:0010677) |
0.8 | 5.5 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.8 | 5.5 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.8 | 3.9 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
0.8 | 6.3 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.8 | 3.9 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
0.8 | 12.5 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.8 | 2.3 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.8 | 24.8 | GO:0006582 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
0.8 | 1.5 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.8 | 9.2 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.8 | 0.8 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.7 | 1.5 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.7 | 4.5 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.7 | 8.0 | GO:1990090 | cellular response to nerve growth factor stimulus(GO:1990090) |
0.7 | 9.4 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.7 | 2.2 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.7 | 2.9 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.7 | 6.2 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.7 | 6.9 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.7 | 4.8 | GO:0090382 | phagosome maturation(GO:0090382) |
0.7 | 6.1 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.7 | 0.7 | GO:0045649 | regulation of macrophage differentiation(GO:0045649) |
0.7 | 0.7 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.7 | 5.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.7 | 34.0 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.7 | 2.0 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.7 | 1.3 | GO:0051561 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.7 | 11.2 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.6 | 1.9 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.6 | 10.8 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.6 | 8.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.6 | 2.5 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.6 | 1.9 | GO:0061031 | subthalamic nucleus development(GO:0021763) prolactin secreting cell differentiation(GO:0060127) left lung development(GO:0060459) left lung morphogenesis(GO:0060460) pulmonary vein morphogenesis(GO:0060577) superior vena cava morphogenesis(GO:0060578) endodermal digestive tract morphogenesis(GO:0061031) |
0.6 | 10.8 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.6 | 2.9 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.6 | 1.1 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
0.6 | 2.8 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.5 | 2.1 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.5 | 20.0 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.5 | 1.6 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.5 | 2.6 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.5 | 9.8 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.5 | 3.1 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.5 | 6.1 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.5 | 3.5 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.5 | 1.5 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.5 | 3.9 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.5 | 3.0 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
0.5 | 45.0 | GO:0071774 | response to fibroblast growth factor(GO:0071774) |
0.5 | 1.9 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.5 | 0.5 | GO:0052564 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
0.5 | 31.4 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.5 | 1.4 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.5 | 9.8 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.5 | 4.1 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.4 | 4.5 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.4 | 2.7 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.4 | 3.1 | GO:0007143 | female meiotic division(GO:0007143) |
0.4 | 4.8 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.4 | 5.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.4 | 1.6 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.4 | 3.6 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.4 | 2.8 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.4 | 1.6 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.4 | 1.1 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.4 | 1.5 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
0.4 | 5.4 | GO:0051149 | positive regulation of muscle cell differentiation(GO:0051149) |
0.4 | 2.5 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.3 | 0.7 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.3 | 0.7 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.3 | 23.2 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.3 | 2.1 | GO:0009642 | response to light intensity(GO:0009642) |
0.3 | 0.9 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.3 | 1.2 | GO:0061117 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of heart growth(GO:0061117) |
0.3 | 1.2 | GO:0015677 | copper ion import(GO:0015677) |
0.3 | 1.6 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.3 | 0.3 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.3 | 1.0 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.3 | 0.5 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
0.2 | 1.0 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
0.2 | 1.7 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.2 | 1.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.2 | 0.9 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.2 | 2.5 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.2 | 2.0 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.2 | 3.6 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.2 | 4.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 0.2 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.2 | 0.6 | GO:1902081 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
0.2 | 1.2 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.2 | 0.8 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.2 | 4.1 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.2 | 0.6 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 0.7 | GO:0033306 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
0.2 | 0.7 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
0.2 | 0.7 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.2 | 0.9 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.2 | 6.2 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.2 | 0.3 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 0.6 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.6 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 1.6 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.7 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.1 | 0.6 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.9 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 0.7 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.2 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
0.1 | 0.7 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 0.1 | GO:0048313 | Golgi inheritance(GO:0048313) |
0.1 | 0.7 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
0.1 | 1.3 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.2 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 6.8 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
0.1 | 0.3 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.1 | 0.5 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 0.3 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.1 | 0.2 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) arterial endothelial cell differentiation(GO:0060842) |
0.1 | 0.2 | GO:0048014 | Tie signaling pathway(GO:0048014) negative regulation of positive chemotaxis(GO:0050928) |
0.1 | 0.5 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.5 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.1 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.0 | 0.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.1 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.0 | 0.1 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
100.7 | 1006.9 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
79.4 | 238.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
73.8 | 369.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
69.2 | 484.4 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
66.0 | 264.2 | GO:0005683 | U7 snRNP(GO:0005683) |
63.8 | 766.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
46.2 | 46.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
45.2 | 316.1 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
44.1 | 220.6 | GO:1902560 | GMP reductase complex(GO:1902560) |
44.1 | 88.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
44.1 | 396.5 | GO:0005787 | signal peptidase complex(GO:0005787) |
43.8 | 131.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
43.0 | 172.1 | GO:0071986 | Ragulator complex(GO:0071986) |
40.4 | 121.3 | GO:0018444 | translation release factor complex(GO:0018444) |
39.2 | 391.8 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
38.8 | 194.1 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
35.2 | 105.6 | GO:0071817 | MMXD complex(GO:0071817) |
34.9 | 349.1 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
34.3 | 205.8 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
32.0 | 192.3 | GO:0034709 | methylosome(GO:0034709) |
31.8 | 254.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
31.7 | 126.8 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
31.6 | 221.3 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
31.2 | 218.3 | GO:0032021 | NELF complex(GO:0032021) |
31.0 | 620.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
31.0 | 185.7 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
30.9 | 30.9 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
30.7 | 92.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
29.8 | 59.7 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
29.5 | 236.3 | GO:0005688 | U6 snRNP(GO:0005688) |
29.1 | 406.7 | GO:0005686 | U2 snRNP(GO:0005686) |
28.7 | 86.2 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
28.5 | 313.9 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
27.5 | 247.6 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
27.5 | 247.3 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
27.2 | 896.5 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
26.9 | 295.5 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
26.5 | 79.5 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
26.2 | 183.5 | GO:0090661 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
25.6 | 230.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
25.2 | 454.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
25.0 | 150.2 | GO:0071797 | LUBAC complex(GO:0071797) |
24.9 | 199.1 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
24.1 | 120.7 | GO:0033503 | HULC complex(GO:0033503) |
23.3 | 139.7 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
23.2 | 116.2 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
23.1 | 69.2 | GO:0097441 | basilar dendrite(GO:0097441) |
22.9 | 68.8 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
22.7 | 113.4 | GO:0097149 | centralspindlin complex(GO:0097149) |
22.5 | 67.5 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
21.6 | 86.5 | GO:0071920 | cleavage body(GO:0071920) |
21.4 | 256.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
21.1 | 63.2 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
21.0 | 168.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
20.8 | 104.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
20.7 | 310.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
20.6 | 267.5 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
20.5 | 225.4 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
20.4 | 387.0 | GO:0030686 | 90S preribosome(GO:0030686) |
20.1 | 362.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
20.1 | 160.9 | GO:0070522 | nucleotide-excision repair factor 1 complex(GO:0000110) ERCC4-ERCC1 complex(GO:0070522) |
20.0 | 199.9 | GO:0097255 | R2TP complex(GO:0097255) |
19.9 | 536.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
19.5 | 58.6 | GO:0034677 | integrin alpha7-beta1 complex(GO:0034677) |
19.4 | 77.8 | GO:0071159 | NF-kappaB complex(GO:0071159) |
19.0 | 114.1 | GO:0061617 | MICOS complex(GO:0061617) |
18.6 | 167.6 | GO:0032133 | chromosome passenger complex(GO:0032133) |
18.6 | 55.7 | GO:0034271 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
18.4 | 92.2 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
18.2 | 182.1 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
18.2 | 72.7 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
17.9 | 17.9 | GO:0005687 | U4 snRNP(GO:0005687) |
17.8 | 1854.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
17.2 | 120.6 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
17.2 | 68.7 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
17.1 | 274.2 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
17.1 | 205.4 | GO:0071203 | WASH complex(GO:0071203) |
17.0 | 51.0 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
16.5 | 462.3 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
15.8 | 31.6 | GO:0035061 | interchromatin granule(GO:0035061) |
15.7 | 62.8 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
15.6 | 124.9 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
15.5 | 108.4 | GO:0016272 | prefoldin complex(GO:0016272) |
15.4 | 215.7 | GO:0090543 | Flemming body(GO:0090543) |
15.2 | 106.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
15.1 | 121.1 | GO:0000796 | condensin complex(GO:0000796) |
15.1 | 256.5 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
15.1 | 45.2 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
14.8 | 607.3 | GO:0015934 | large ribosomal subunit(GO:0015934) |
14.6 | 29.3 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
14.6 | 58.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
14.5 | 303.9 | GO:0097342 | ripoptosome(GO:0097342) |
14.3 | 43.0 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
14.2 | 71.2 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
14.2 | 412.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
14.2 | 99.6 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
14.0 | 84.0 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
13.8 | 69.0 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
13.7 | 68.4 | GO:0070765 | gamma-secretase complex(GO:0070765) |
13.6 | 54.4 | GO:0030904 | retromer complex(GO:0030904) |
13.5 | 53.9 | GO:0070876 | SOSS complex(GO:0070876) |
13.4 | 53.5 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
13.4 | 160.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
13.3 | 199.6 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
13.2 | 210.9 | GO:0032040 | small-subunit processome(GO:0032040) |
13.2 | 171.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
13.2 | 52.6 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
12.8 | 51.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
12.6 | 63.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
12.6 | 151.3 | GO:0042555 | MCM complex(GO:0042555) |
12.4 | 148.5 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
12.3 | 160.0 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
12.3 | 159.7 | GO:0036452 | ESCRT complex(GO:0036452) |
12.2 | 146.5 | GO:0030008 | TRAPP complex(GO:0030008) |
12.2 | 36.5 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
12.2 | 109.4 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
12.0 | 36.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
12.0 | 168.4 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
12.0 | 48.1 | GO:0000811 | GINS complex(GO:0000811) |
12.0 | 71.7 | GO:0070552 | BRISC complex(GO:0070552) |
11.9 | 35.7 | GO:0030684 | preribosome(GO:0030684) |
11.8 | 59.0 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
11.7 | 727.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
11.5 | 80.6 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
11.4 | 250.5 | GO:0036020 | endolysosome membrane(GO:0036020) |
11.3 | 124.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
11.3 | 11.3 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
11.2 | 112.3 | GO:0032039 | integrator complex(GO:0032039) |
11.0 | 121.5 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
10.9 | 10.9 | GO:0001652 | granular component(GO:0001652) |
10.7 | 53.5 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
10.4 | 94.0 | GO:0042382 | paraspeckles(GO:0042382) |
10.2 | 122.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
10.1 | 50.7 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
10.1 | 140.9 | GO:0005685 | U1 snRNP(GO:0005685) |
10.0 | 100.4 | GO:0044194 | cytolytic granule(GO:0044194) |
10.0 | 90.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
10.0 | 49.9 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
10.0 | 39.9 | GO:0031298 | replication fork protection complex(GO:0031298) |
10.0 | 29.9 | GO:0031262 | Ndc80 complex(GO:0031262) |
9.9 | 49.7 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
9.9 | 39.4 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
9.8 | 29.3 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
9.7 | 107.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
9.7 | 19.4 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
9.7 | 87.4 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
9.5 | 76.3 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
9.2 | 46.2 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
9.2 | 27.7 | GO:0070939 | Dsl1p complex(GO:0070939) |
9.2 | 220.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
9.2 | 27.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
9.1 | 463.0 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
9.1 | 1115.9 | GO:0035578 | azurophil granule lumen(GO:0035578) |
9.0 | 126.5 | GO:0001673 | male germ cell nucleus(GO:0001673) |
9.0 | 135.0 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
9.0 | 44.9 | GO:0032044 | DSIF complex(GO:0032044) |
9.0 | 71.7 | GO:0097452 | GAIT complex(GO:0097452) |
9.0 | 26.9 | GO:1990913 | sperm head plasma membrane(GO:1990913) ooplasm(GO:1990917) |
8.7 | 87.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
8.6 | 51.7 | GO:0060171 | stereocilium membrane(GO:0060171) |
8.4 | 33.7 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
8.4 | 58.9 | GO:0015935 | small ribosomal subunit(GO:0015935) |
8.4 | 25.2 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
8.4 | 276.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
8.4 | 8.4 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
8.2 | 24.5 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
7.9 | 1272.0 | GO:0005681 | spliceosomal complex(GO:0005681) |
7.9 | 39.7 | GO:0089701 | U2AF(GO:0089701) |
7.9 | 87.4 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
7.9 | 39.7 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
7.9 | 118.5 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
7.9 | 157.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
7.8 | 86.3 | GO:0030870 | Mre11 complex(GO:0030870) |
7.8 | 23.5 | GO:0000805 | X chromosome(GO:0000805) |
7.7 | 77.3 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
7.7 | 162.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
7.6 | 434.6 | GO:0035577 | azurophil granule membrane(GO:0035577) |
7.6 | 22.8 | GO:0008623 | CHRAC(GO:0008623) |
7.5 | 37.7 | GO:0031523 | Myb complex(GO:0031523) |
7.4 | 29.8 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
7.4 | 51.8 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
7.4 | 95.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
7.3 | 50.9 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
7.2 | 14.3 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
7.1 | 35.5 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
7.0 | 7.0 | GO:0055087 | Ski complex(GO:0055087) |
7.0 | 396.9 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
6.9 | 34.7 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
6.9 | 48.5 | GO:0034518 | RNA cap binding complex(GO:0034518) |
6.9 | 48.4 | GO:0043203 | axon hillock(GO:0043203) |
6.9 | 89.4 | GO:0031209 | SCAR complex(GO:0031209) |
6.9 | 27.4 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
6.6 | 39.6 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
6.6 | 203.2 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
6.5 | 32.7 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
6.5 | 52.2 | GO:0042588 | zymogen granule(GO:0042588) |
6.5 | 91.2 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
6.5 | 32.4 | GO:0032301 | MutSalpha complex(GO:0032301) |
6.5 | 25.8 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
6.4 | 147.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
6.4 | 44.8 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
6.4 | 12.8 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
6.4 | 19.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
6.3 | 279.2 | GO:0090544 | BAF-type complex(GO:0090544) |
6.3 | 69.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
6.3 | 332.4 | GO:0001772 | immunological synapse(GO:0001772) |
6.2 | 31.0 | GO:0030891 | VCB complex(GO:0030891) |
6.2 | 265.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
6.1 | 12.2 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
6.1 | 12.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
6.0 | 12.1 | GO:0042627 | chylomicron(GO:0042627) |
6.0 | 18.0 | GO:1990423 | RZZ complex(GO:1990423) |
6.0 | 221.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
5.9 | 17.8 | GO:0030312 | external encapsulating structure(GO:0030312) |
5.9 | 437.6 | GO:0005643 | nuclear pore(GO:0005643) |
5.9 | 41.3 | GO:0001520 | outer dense fiber(GO:0001520) |
5.8 | 5.8 | GO:1904724 | tertiary granule lumen(GO:1904724) |
5.7 | 435.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
5.7 | 260.0 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
5.6 | 84.0 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
5.5 | 60.8 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
5.5 | 27.3 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
5.4 | 75.8 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
5.3 | 21.1 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
5.2 | 46.9 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
5.1 | 77.2 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
5.1 | 15.4 | GO:1990038 | glial cytoplasmic inclusion(GO:0097409) classical Lewy body(GO:0097414) Lewy neurite(GO:0097462) Lewy body corona(GO:1990038) |
5.1 | 56.2 | GO:0070449 | elongin complex(GO:0070449) |
5.1 | 86.8 | GO:0035631 | CD40 receptor complex(GO:0035631) |
5.1 | 15.2 | GO:1902636 | kinociliary basal body(GO:1902636) |
4.9 | 14.7 | GO:0098576 | lumenal side of membrane(GO:0098576) |
4.8 | 53.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
4.8 | 14.5 | GO:0033167 | ARC complex(GO:0033167) |
4.8 | 28.8 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
4.8 | 23.8 | GO:0005839 | proteasome core complex(GO:0005839) |
4.7 | 32.9 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
4.7 | 233.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
4.6 | 36.7 | GO:0032010 | phagolysosome(GO:0032010) |
4.5 | 22.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
4.5 | 45.4 | GO:0001891 | phagocytic cup(GO:0001891) |
4.5 | 237.1 | GO:0005840 | ribosome(GO:0005840) |
4.5 | 31.3 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
4.5 | 107.1 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
4.5 | 303.2 | GO:0005637 | nuclear inner membrane(GO:0005637) |
4.4 | 605.0 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
4.4 | 35.5 | GO:0097413 | Lewy body(GO:0097413) |
4.4 | 382.7 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
4.3 | 13.0 | GO:0035517 | PR-DUB complex(GO:0035517) |
4.3 | 34.2 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
4.2 | 41.9 | GO:0032585 | multivesicular body membrane(GO:0032585) |
4.2 | 25.1 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
4.2 | 20.8 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
4.1 | 8.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
4.1 | 20.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
4.1 | 20.4 | GO:0000346 | transcription export complex(GO:0000346) |
4.0 | 52.2 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
4.0 | 39.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
3.9 | 11.7 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
3.9 | 11.6 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
3.8 | 23.0 | GO:0032279 | asymmetric synapse(GO:0032279) |
3.8 | 546.6 | GO:0005903 | brush border(GO:0005903) |
3.8 | 41.4 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
3.7 | 1391.7 | GO:0016607 | nuclear speck(GO:0016607) |
3.7 | 62.5 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
3.7 | 36.7 | GO:0035861 | site of double-strand break(GO:0035861) |
3.6 | 40.1 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
3.6 | 14.6 | GO:0022624 | proteasome accessory complex(GO:0022624) |
3.6 | 7.3 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
3.6 | 101.7 | GO:0005657 | replication fork(GO:0005657) |
3.5 | 187.2 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
3.4 | 13.8 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
3.4 | 365.5 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
3.4 | 10.1 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
3.4 | 47.1 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
3.3 | 320.4 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
3.3 | 171.6 | GO:0005871 | kinesin complex(GO:0005871) |
3.3 | 110.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
3.2 | 32.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
3.2 | 25.9 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
3.2 | 6.5 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
3.2 | 6.4 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
3.2 | 9.6 | GO:0005745 | m-AAA complex(GO:0005745) |
3.2 | 3.2 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
3.1 | 72.4 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
3.1 | 6.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
3.0 | 36.3 | GO:0031528 | microvillus membrane(GO:0031528) |
3.0 | 47.7 | GO:0000502 | proteasome complex(GO:0000502) |
3.0 | 8.9 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
3.0 | 20.7 | GO:0070652 | HAUS complex(GO:0070652) |
2.9 | 20.3 | GO:0030057 | desmosome(GO:0030057) |
2.8 | 2.8 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
2.8 | 39.8 | GO:0000812 | Swr1 complex(GO:0000812) |
2.8 | 36.9 | GO:0016600 | flotillin complex(GO:0016600) |
2.8 | 48.0 | GO:0002102 | podosome(GO:0002102) |
2.7 | 658.4 | GO:0019866 | organelle inner membrane(GO:0019866) |
2.7 | 32.4 | GO:0070938 | contractile ring(GO:0070938) |
2.7 | 43.1 | GO:0031932 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
2.7 | 13.4 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
2.7 | 2.7 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
2.7 | 10.6 | GO:0005876 | spindle microtubule(GO:0005876) |
2.6 | 10.5 | GO:0044307 | dendritic branch(GO:0044307) |
2.6 | 49.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
2.5 | 15.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
2.5 | 325.9 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
2.5 | 211.2 | GO:0070821 | tertiary granule membrane(GO:0070821) |
2.5 | 15.2 | GO:0097451 | astrocyte end-foot(GO:0097450) glial limiting end-foot(GO:0097451) |
2.5 | 27.6 | GO:0000124 | SAGA complex(GO:0000124) |
2.5 | 318.5 | GO:0000793 | condensed chromosome(GO:0000793) |
2.5 | 20.0 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
2.5 | 7.4 | GO:0071439 | clathrin complex(GO:0071439) |
2.5 | 4.9 | GO:0032059 | bleb(GO:0032059) |
2.4 | 7.3 | GO:0071750 | dimeric IgA immunoglobulin complex(GO:0071750) secretory dimeric IgA immunoglobulin complex(GO:0071752) |
2.4 | 17.0 | GO:0030677 | ribonuclease P complex(GO:0030677) |
2.4 | 2.4 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
2.4 | 7.2 | GO:0044754 | autolysosome(GO:0044754) |
2.4 | 92.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
2.3 | 2.3 | GO:0043073 | germ cell nucleus(GO:0043073) |
2.3 | 58.0 | GO:0000776 | kinetochore(GO:0000776) |
2.3 | 4.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
2.3 | 173.3 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
2.3 | 50.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
2.3 | 38.8 | GO:0035580 | specific granule lumen(GO:0035580) |
2.3 | 6.8 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
2.2 | 15.5 | GO:0070822 | Sin3-type complex(GO:0070822) |
2.2 | 30.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
2.2 | 21.8 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
2.2 | 134.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
2.2 | 2.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
2.1 | 10.6 | GO:1902555 | endoribonuclease complex(GO:1902555) |
2.1 | 8.3 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
2.0 | 66.9 | GO:0031258 | lamellipodium membrane(GO:0031258) |
2.0 | 8.0 | GO:0032433 | filopodium tip(GO:0032433) |
2.0 | 2.0 | GO:0044308 | axonal spine(GO:0044308) |
2.0 | 46.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
2.0 | 7.9 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
1.9 | 18.9 | GO:0051233 | spindle midzone(GO:0051233) |
1.9 | 15.0 | GO:0030056 | hemidesmosome(GO:0030056) |
1.8 | 24.8 | GO:0000145 | exocyst(GO:0000145) |
1.8 | 5.3 | GO:1990393 | 3M complex(GO:1990393) |
1.7 | 13.9 | GO:0070852 | cell body fiber(GO:0070852) |
1.7 | 122.0 | GO:0016459 | myosin complex(GO:0016459) |
1.6 | 486.4 | GO:0005635 | nuclear envelope(GO:0005635) |
1.6 | 7.8 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
1.6 | 4.7 | GO:0032389 | MutLalpha complex(GO:0032389) |
1.5 | 3.1 | GO:0097431 | mitotic spindle pole(GO:0097431) |
1.5 | 54.8 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
1.5 | 82.0 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
1.5 | 11.9 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
1.5 | 71.8 | GO:0005795 | Golgi stack(GO:0005795) |
1.4 | 54.5 | GO:0045095 | keratin filament(GO:0045095) |
1.4 | 5.7 | GO:0048179 | activin receptor complex(GO:0048179) |
1.4 | 4.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.4 | 123.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
1.3 | 10.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.3 | 45.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
1.3 | 6.6 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
1.3 | 151.7 | GO:1990904 | ribonucleoprotein complex(GO:1990904) |
1.3 | 2.6 | GO:0000788 | nuclear nucleosome(GO:0000788) |
1.3 | 8.8 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
1.3 | 63.0 | GO:0042571 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
1.3 | 6.3 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
1.2 | 78.0 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
1.2 | 1.2 | GO:0097449 | astrocyte projection(GO:0097449) |
1.1 | 22.2 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
1.1 | 4.4 | GO:0019867 | outer membrane(GO:0019867) |
1.1 | 57.4 | GO:0031966 | mitochondrial membrane(GO:0031966) |
1.1 | 2579.4 | GO:0070062 | extracellular exosome(GO:0070062) |
1.0 | 73.5 | GO:0000922 | spindle pole(GO:0000922) |
0.9 | 6.3 | GO:0031941 | filamentous actin(GO:0031941) |
0.9 | 2.7 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.9 | 10.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.9 | 10.3 | GO:0044216 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.9 | 2.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.8 | 3.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.8 | 24.0 | GO:0016235 | aggresome(GO:0016235) |
0.8 | 23.9 | GO:0045171 | intercellular bridge(GO:0045171) |
0.8 | 1.5 | GO:0072487 | MSL complex(GO:0072487) |
0.6 | 3.7 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.6 | 34.9 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.6 | 25.8 | GO:0005776 | autophagosome(GO:0005776) |
0.6 | 5.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.5 | 1.0 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.4 | 7.8 | GO:0042581 | specific granule(GO:0042581) |
0.4 | 4.1 | GO:0005605 | basal lamina(GO:0005605) |
0.3 | 1.4 | GO:0001739 | sex chromatin(GO:0001739) |
0.3 | 2.0 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.3 | 0.6 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.3 | 0.8 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 0.7 | GO:0043512 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.2 | 1.8 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 0.6 | GO:0033150 | perinuclear theca(GO:0033011) cytoskeletal calyx(GO:0033150) |
0.2 | 4.6 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 1.4 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 0.5 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
88.7 | 266.2 | GO:0098808 | mRNA cap binding(GO:0098808) |
79.4 | 238.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
64.9 | 519.1 | GO:0070990 | snRNP binding(GO:0070990) |
59.3 | 177.8 | GO:0044713 | GTP diphosphatase activity(GO:0036219) 2-hydroxy-adenosine triphosphate pyrophosphatase activity(GO:0044713) 2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity(GO:0044714) ATP diphosphatase activity(GO:0047693) |
56.9 | 113.8 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
54.2 | 162.6 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
52.0 | 363.9 | GO:0030620 | U2 snRNA binding(GO:0030620) |
48.4 | 532.8 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
44.5 | 1247.0 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
44.1 | 220.6 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
43.4 | 130.3 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
42.5 | 170.2 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
38.7 | 309.6 | GO:0030621 | U4 snRNA binding(GO:0030621) |
38.6 | 347.6 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
37.7 | 376.8 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
36.1 | 252.8 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
35.4 | 177.0 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
34.6 | 241.9 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
34.1 | 102.4 | GO:0005046 | KDEL sequence binding(GO:0005046) |
32.3 | 258.0 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
32.2 | 96.6 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
31.8 | 254.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
31.7 | 126.8 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
31.6 | 189.8 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
30.6 | 122.5 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
30.1 | 120.3 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
29.4 | 264.7 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
27.1 | 27.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
27.0 | 81.0 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
26.8 | 80.4 | GO:0031753 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
26.3 | 78.8 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
26.2 | 183.5 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
26.0 | 104.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
25.9 | 155.3 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
25.5 | 178.4 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
24.3 | 97.4 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
24.0 | 144.2 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
23.9 | 23.9 | GO:0032405 | MutLalpha complex binding(GO:0032405) MutSalpha complex binding(GO:0032407) |
23.7 | 142.5 | GO:0005047 | signal recognition particle binding(GO:0005047) |
23.5 | 70.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
23.0 | 69.1 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
23.0 | 459.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
22.7 | 22.7 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
22.4 | 134.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
22.4 | 246.6 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
22.2 | 110.8 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
22.0 | 88.0 | GO:0004360 | glutamine-fructose-6-phosphate transaminase (isomerizing) activity(GO:0004360) |
21.9 | 197.0 | GO:0035174 | histone serine kinase activity(GO:0035174) |
21.5 | 451.5 | GO:0043495 | protein anchor(GO:0043495) |
21.1 | 168.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
20.9 | 125.4 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
20.8 | 104.0 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
20.8 | 145.5 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
20.4 | 40.9 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
20.4 | 142.9 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) ATP transmembrane transporter activity(GO:0005347) purine nucleotide transmembrane transporter activity(GO:0015216) ADP transmembrane transporter activity(GO:0015217) |
20.3 | 81.3 | GO:0098770 | FBXO family protein binding(GO:0098770) |
20.2 | 121.4 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
20.2 | 60.6 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
20.1 | 160.9 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
20.1 | 220.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
20.0 | 120.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
19.9 | 59.6 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
19.7 | 1316.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
19.6 | 137.4 | GO:0016531 | copper chaperone activity(GO:0016531) |
19.6 | 58.8 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
19.3 | 77.3 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
19.1 | 57.4 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
18.9 | 56.6 | GO:0070538 | oleic acid binding(GO:0070538) |
18.7 | 56.2 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
18.7 | 56.2 | GO:0042947 | glucoside transmembrane transporter activity(GO:0042947) |
18.6 | 55.8 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
18.5 | 333.1 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
18.4 | 110.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
17.8 | 142.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
17.0 | 203.9 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
17.0 | 288.3 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
17.0 | 50.9 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
16.8 | 84.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
16.8 | 134.7 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
16.8 | 117.6 | GO:0015266 | protein channel activity(GO:0015266) |
16.6 | 33.2 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
16.3 | 260.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
16.2 | 48.5 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
16.1 | 48.4 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
16.1 | 80.4 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
16.0 | 47.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
15.7 | 78.7 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
15.7 | 439.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
15.7 | 62.7 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
15.7 | 47.0 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
15.6 | 124.8 | GO:0050733 | RS domain binding(GO:0050733) |
15.5 | 450.8 | GO:0017025 | TBP-class protein binding(GO:0017025) |
15.5 | 46.4 | GO:0009041 | uridylate kinase activity(GO:0009041) |
15.4 | 725.7 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
15.0 | 134.9 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
15.0 | 89.7 | GO:0035500 | MH2 domain binding(GO:0035500) |
14.9 | 74.6 | GO:0016936 | galactoside binding(GO:0016936) |
14.9 | 89.3 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
14.9 | 74.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
14.8 | 29.6 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
14.7 | 44.2 | GO:0004766 | spermidine synthase activity(GO:0004766) |
14.7 | 175.9 | GO:0031386 | protein tag(GO:0031386) |
14.7 | 44.0 | GO:0031403 | lithium ion binding(GO:0031403) |
14.6 | 58.5 | GO:0003883 | CTP synthase activity(GO:0003883) |
14.5 | 2888.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
14.2 | 71.0 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
14.1 | 155.6 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
14.1 | 28.1 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
14.1 | 98.5 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
14.0 | 28.0 | GO:0001129 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
13.9 | 27.9 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
13.9 | 97.1 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
13.8 | 207.6 | GO:0000339 | RNA cap binding(GO:0000339) |
13.7 | 41.2 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
13.7 | 27.4 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
13.5 | 67.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
13.3 | 66.6 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
13.3 | 106.4 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
13.3 | 66.5 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
13.3 | 39.8 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
13.2 | 52.6 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
12.9 | 64.6 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
12.8 | 38.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
12.7 | 38.1 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
12.7 | 38.1 | GO:0055100 | adiponectin binding(GO:0055100) |
12.7 | 38.1 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
12.7 | 291.1 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
12.6 | 50.5 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
12.5 | 224.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
12.5 | 62.3 | GO:0089720 | caspase binding(GO:0089720) |
12.3 | 98.7 | GO:0008097 | 5S rRNA binding(GO:0008097) |
12.3 | 135.0 | GO:0016004 | phospholipase activator activity(GO:0016004) |
12.1 | 121.4 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
12.0 | 12.0 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
12.0 | 59.9 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
12.0 | 35.9 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
11.9 | 95.0 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
11.8 | 47.4 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
11.8 | 449.1 | GO:0005123 | death receptor binding(GO:0005123) |
11.8 | 82.6 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
11.7 | 70.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
11.7 | 70.4 | GO:0016748 | succinyltransferase activity(GO:0016748) |
11.7 | 82.0 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
11.6 | 93.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
11.6 | 93.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
11.5 | 80.7 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
11.5 | 34.6 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
11.5 | 46.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
11.5 | 275.5 | GO:0031369 | translation initiation factor binding(GO:0031369) |
11.5 | 332.1 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
11.4 | 34.1 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
11.4 | 79.5 | GO:0050815 | phosphoserine binding(GO:0050815) |
11.3 | 45.3 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
11.3 | 67.9 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
11.3 | 11.3 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
11.3 | 45.1 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
11.3 | 33.8 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
11.1 | 11.1 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
11.1 | 143.8 | GO:0030515 | snoRNA binding(GO:0030515) |
11.0 | 297.1 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
11.0 | 417.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
11.0 | 76.8 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
11.0 | 460.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
10.9 | 186.0 | GO:0050786 | RAGE receptor binding(GO:0050786) |
10.9 | 32.6 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
10.8 | 54.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
10.5 | 42.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
10.4 | 31.3 | GO:0032089 | NACHT domain binding(GO:0032089) |
10.4 | 41.6 | GO:0033897 | ribonuclease T2 activity(GO:0033897) |
10.3 | 31.0 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
10.3 | 195.1 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
10.3 | 82.0 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
10.2 | 40.8 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
10.2 | 20.4 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
10.2 | 254.0 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
10.1 | 60.8 | GO:0048256 | flap endonuclease activity(GO:0048256) |
10.1 | 40.3 | GO:0032184 | SUMO polymer binding(GO:0032184) |
10.0 | 29.9 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
9.9 | 29.8 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
9.8 | 39.4 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
9.8 | 235.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
9.8 | 29.4 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
9.7 | 185.0 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
9.7 | 38.9 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
9.7 | 58.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
9.7 | 194.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
9.7 | 38.7 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
9.7 | 29.0 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
9.6 | 347.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
9.6 | 105.7 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
9.6 | 19.1 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
9.6 | 47.8 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
9.4 | 216.4 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
9.4 | 103.4 | GO:0046790 | virion binding(GO:0046790) |
9.3 | 112.2 | GO:0008143 | poly(A) binding(GO:0008143) |
9.3 | 56.1 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
9.3 | 121.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
9.3 | 93.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
9.2 | 27.7 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
9.2 | 36.7 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
9.2 | 54.9 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
9.2 | 45.8 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
9.1 | 45.5 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
9.0 | 18.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
9.0 | 153.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
8.9 | 26.8 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
8.9 | 44.6 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
8.8 | 79.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
8.5 | 25.6 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
8.5 | 50.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
8.4 | 58.9 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
8.4 | 42.0 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
8.4 | 142.4 | GO:0051400 | BH domain binding(GO:0051400) |
8.4 | 217.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
8.3 | 66.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
8.2 | 393.6 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
8.0 | 24.0 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
8.0 | 224.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
8.0 | 63.9 | GO:0019237 | centromeric DNA binding(GO:0019237) |
7.9 | 39.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
7.9 | 15.8 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
7.9 | 23.6 | GO:0032090 | Pyrin domain binding(GO:0032090) |
7.9 | 39.4 | GO:0051998 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
7.8 | 101.4 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
7.8 | 23.3 | GO:0047315 | kynurenine-glyoxylate transaminase activity(GO:0047315) |
7.6 | 91.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
7.6 | 22.9 | GO:0044594 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
7.6 | 60.9 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
7.6 | 45.6 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
7.6 | 22.7 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
7.6 | 15.1 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
7.5 | 22.6 | GO:0033699 | DNA 5'-adenosine monophosphate hydrolase activity(GO:0033699) |
7.5 | 97.7 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
7.5 | 164.9 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
7.4 | 29.7 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
7.3 | 22.0 | GO:0097677 | STAT family protein binding(GO:0097677) |
7.3 | 43.9 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
7.2 | 21.7 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
7.1 | 21.4 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
7.1 | 142.6 | GO:0048156 | tau protein binding(GO:0048156) |
7.1 | 7.1 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
7.0 | 56.0 | GO:0030274 | LIM domain binding(GO:0030274) |
7.0 | 13.9 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
7.0 | 55.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
7.0 | 20.9 | GO:0080023 | 3R-hydroxyacyl-CoA dehydratase activity(GO:0080023) |
6.9 | 20.8 | GO:0047756 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) chondroitin 4-sulfotransferase activity(GO:0047756) |
6.9 | 311.2 | GO:0050699 | WW domain binding(GO:0050699) |
6.9 | 27.5 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
6.9 | 34.3 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
6.9 | 20.6 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
6.7 | 107.8 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
6.7 | 127.7 | GO:0043422 | protein kinase B binding(GO:0043422) |
6.7 | 33.6 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
6.7 | 349.2 | GO:0031593 | polyubiquitin binding(GO:0031593) |
6.7 | 93.8 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
6.7 | 33.5 | GO:0030613 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
6.6 | 39.9 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
6.6 | 33.1 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
6.6 | 131.6 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
6.5 | 327.1 | GO:0031491 | nucleosome binding(GO:0031491) |
6.5 | 32.7 | GO:0036033 | mediator complex binding(GO:0036033) |
6.5 | 39.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
6.5 | 651.3 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
6.5 | 19.5 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) interleukin-5 receptor activity(GO:0004914) |
6.4 | 154.6 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
6.3 | 19.0 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
6.3 | 12.6 | GO:0046979 | TAP2 binding(GO:0046979) |
6.2 | 149.8 | GO:0031489 | myosin V binding(GO:0031489) |
6.2 | 18.5 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
6.2 | 18.5 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
6.1 | 43.0 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
6.1 | 18.4 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
6.1 | 18.3 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
6.1 | 18.2 | GO:0002046 | opsin binding(GO:0002046) |
6.1 | 249.0 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
6.1 | 6.1 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
6.0 | 47.9 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
6.0 | 24.0 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
5.9 | 249.8 | GO:0017091 | AU-rich element binding(GO:0017091) |
5.9 | 17.8 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
5.9 | 35.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
5.9 | 23.4 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
5.8 | 46.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
5.8 | 46.3 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
5.8 | 23.1 | GO:0048039 | ubiquinone binding(GO:0048039) |
5.7 | 17.2 | GO:0003860 | 3-hydroxyisobutyryl-CoA hydrolase activity(GO:0003860) |
5.7 | 39.9 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
5.7 | 17.1 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
5.7 | 17.0 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
5.6 | 28.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
5.6 | 28.0 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
5.6 | 16.8 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
5.6 | 61.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
5.6 | 22.3 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
5.6 | 38.9 | GO:0035197 | siRNA binding(GO:0035197) |
5.6 | 16.7 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
5.5 | 332.5 | GO:0019003 | GDP binding(GO:0019003) |
5.5 | 82.5 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
5.5 | 38.3 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
5.4 | 21.7 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
5.4 | 10.8 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
5.4 | 16.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
5.4 | 85.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
5.3 | 15.9 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
5.3 | 21.2 | GO:0070404 | NADH binding(GO:0070404) |
5.3 | 37.1 | GO:0004459 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
5.3 | 15.9 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
5.3 | 15.9 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
5.3 | 36.9 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
5.3 | 36.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
5.2 | 162.6 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
5.2 | 198.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
5.2 | 46.9 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
5.2 | 5.2 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
5.2 | 25.8 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
5.1 | 15.4 | GO:0052836 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
5.1 | 25.5 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
5.1 | 311.5 | GO:0043130 | ubiquitin binding(GO:0043130) |
5.1 | 81.6 | GO:1901612 | cardiolipin binding(GO:1901612) |
5.1 | 55.8 | GO:0019534 | toxin transporter activity(GO:0019534) |
5.0 | 85.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
5.0 | 74.8 | GO:0019211 | phosphatase activator activity(GO:0019211) |
5.0 | 99.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
4.9 | 34.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
4.9 | 19.6 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
4.9 | 34.3 | GO:0015288 | porin activity(GO:0015288) |
4.8 | 256.1 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
4.8 | 28.8 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
4.8 | 67.2 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
4.8 | 33.5 | GO:0050700 | CARD domain binding(GO:0050700) |
4.7 | 9.4 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
4.7 | 51.7 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
4.7 | 42.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
4.7 | 37.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
4.7 | 79.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
4.6 | 60.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
4.6 | 69.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
4.6 | 46.0 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
4.6 | 36.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
4.6 | 1704.1 | GO:0045296 | cadherin binding(GO:0045296) |
4.6 | 27.4 | GO:1990763 | arrestin family protein binding(GO:1990763) |
4.5 | 36.2 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
4.4 | 13.3 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
4.4 | 40.0 | GO:0032051 | clathrin light chain binding(GO:0032051) |
4.4 | 13.3 | GO:0031996 | thioesterase binding(GO:0031996) |
4.4 | 39.6 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
4.4 | 13.1 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
4.3 | 446.9 | GO:0008565 | protein transporter activity(GO:0008565) |
4.3 | 17.2 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
4.3 | 12.8 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
4.3 | 25.6 | GO:0004849 | uridine kinase activity(GO:0004849) |
4.3 | 51.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
4.2 | 782.5 | GO:0051015 | actin filament binding(GO:0051015) |
4.2 | 38.0 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
4.2 | 25.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
4.2 | 12.6 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
4.2 | 16.8 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
4.2 | 12.6 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
4.2 | 124.6 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
4.2 | 12.5 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
4.2 | 265.7 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
4.1 | 70.1 | GO:0004697 | protein kinase C activity(GO:0004697) |
4.1 | 516.5 | GO:0047485 | protein N-terminus binding(GO:0047485) |
4.1 | 40.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
4.0 | 28.3 | GO:0034452 | dynactin binding(GO:0034452) |
4.0 | 12.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
3.9 | 19.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
3.9 | 7.8 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
3.9 | 97.8 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
3.9 | 69.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
3.9 | 85.0 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
3.8 | 61.4 | GO:0005537 | mannose binding(GO:0005537) |
3.8 | 106.3 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
3.8 | 41.3 | GO:0019213 | deacetylase activity(GO:0019213) |
3.7 | 11.2 | GO:0016154 | thymidine phosphorylase activity(GO:0009032) pyrimidine-nucleoside phosphorylase activity(GO:0016154) |
3.7 | 29.7 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
3.7 | 11.1 | GO:0004418 | hydroxymethylbilane synthase activity(GO:0004418) |
3.7 | 18.4 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
3.6 | 10.9 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
3.6 | 10.9 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
3.6 | 14.3 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
3.6 | 7.1 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
3.4 | 3.4 | GO:0019239 | deaminase activity(GO:0019239) |
3.4 | 17.1 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
3.4 | 23.7 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
3.3 | 13.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
3.2 | 32.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
3.2 | 25.9 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
3.2 | 25.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
3.2 | 31.8 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
3.2 | 6.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
3.2 | 34.8 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
3.2 | 22.1 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
3.1 | 12.5 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
3.1 | 15.6 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
3.1 | 18.7 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
3.1 | 89.6 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
3.1 | 27.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
3.1 | 18.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
3.1 | 12.3 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
3.0 | 9.1 | GO:0033765 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
3.0 | 125.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
3.0 | 144.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
3.0 | 38.4 | GO:0015926 | glucosidase activity(GO:0015926) |
2.9 | 11.8 | GO:0004420 | hydroxymethylglutaryl-CoA reductase (NADPH) activity(GO:0004420) hydroxymethylglutaryl-CoA reductase activity(GO:0042282) |
2.9 | 17.5 | GO:0003796 | lysozyme activity(GO:0003796) |
2.9 | 25.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
2.8 | 31.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
2.8 | 19.8 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
2.8 | 5.7 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
2.8 | 11.3 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
2.8 | 47.8 | GO:0019992 | diacylglycerol binding(GO:0019992) |
2.8 | 59.0 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
2.8 | 8.4 | GO:1990254 | keratin filament binding(GO:1990254) |
2.8 | 8.4 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
2.7 | 13.7 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
2.7 | 16.4 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
2.7 | 19.1 | GO:0004470 | malic enzyme activity(GO:0004470) |
2.7 | 29.9 | GO:0004985 | opioid receptor activity(GO:0004985) |
2.7 | 35.0 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
2.7 | 13.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
2.7 | 37.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
2.7 | 8.0 | GO:0005534 | galactose binding(GO:0005534) disaccharide binding(GO:0048030) |
2.7 | 13.3 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
2.6 | 34.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
2.6 | 86.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
2.6 | 41.0 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
2.6 | 10.2 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
2.6 | 10.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
2.6 | 35.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
2.5 | 60.4 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
2.5 | 45.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
2.5 | 5.0 | GO:0008988 | rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) |
2.5 | 10.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
2.4 | 2670.4 | GO:0003723 | RNA binding(GO:0003723) |
2.4 | 9.6 | GO:0000182 | rDNA binding(GO:0000182) |
2.4 | 31.0 | GO:0003678 | DNA helicase activity(GO:0003678) |
2.3 | 30.3 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
2.3 | 9.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
2.3 | 6.8 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
2.2 | 20.2 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
2.2 | 35.6 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
2.2 | 13.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
2.2 | 4.4 | GO:0051861 | glycolipid binding(GO:0051861) |
2.2 | 6.6 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
2.2 | 6.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
2.1 | 8.6 | GO:0042834 | peptidoglycan binding(GO:0042834) |
2.1 | 19.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
2.1 | 4.2 | GO:0045182 | translation regulator activity(GO:0045182) |
2.1 | 10.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
2.0 | 6.1 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
2.0 | 57.0 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
2.0 | 18.2 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
2.0 | 67.0 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
2.0 | 9.8 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.9 | 13.5 | GO:0034594 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
1.9 | 5.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
1.9 | 5.7 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
1.9 | 47.0 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
1.9 | 5.6 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
1.9 | 13.0 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
1.8 | 7.4 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
1.8 | 40.2 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
1.8 | 25.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
1.8 | 63.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
1.8 | 12.5 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
1.8 | 15.8 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
1.8 | 56.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
1.8 | 8.8 | GO:0004771 | sterol esterase activity(GO:0004771) |
1.7 | 5.2 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
1.7 | 6.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
1.7 | 18.7 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
1.7 | 5.0 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
1.6 | 4.9 | GO:0035731 | S-nitrosoglutathione binding(GO:0035730) dinitrosyl-iron complex binding(GO:0035731) |
1.6 | 6.5 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
1.6 | 3.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
1.6 | 23.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
1.6 | 12.5 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
1.6 | 6.2 | GO:0097617 | annealing activity(GO:0097617) |
1.6 | 172.9 | GO:0042393 | histone binding(GO:0042393) |
1.5 | 67.0 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
1.5 | 9.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.5 | 10.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
1.4 | 4.3 | GO:0000252 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity(GO:0047012) |
1.4 | 5.7 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
1.4 | 1.4 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
1.4 | 5.7 | GO:0003680 | AT DNA binding(GO:0003680) |
1.4 | 4.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
1.4 | 7.1 | GO:0043274 | phospholipase binding(GO:0043274) |
1.4 | 19.5 | GO:0043531 | ADP binding(GO:0043531) |
1.4 | 20.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
1.4 | 8.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
1.4 | 2.7 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
1.3 | 5.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
1.3 | 13.3 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
1.3 | 48.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
1.3 | 13.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
1.3 | 6.4 | GO:0043426 | MRF binding(GO:0043426) |
1.3 | 7.6 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
1.2 | 14.8 | GO:0005522 | profilin binding(GO:0005522) |
1.2 | 34.5 | GO:0043236 | laminin binding(GO:0043236) |
1.2 | 39.0 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
1.2 | 3.7 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.2 | 8.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.2 | 16.8 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
1.2 | 3.6 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
1.2 | 8.4 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
1.2 | 4.8 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
1.2 | 4.8 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
1.2 | 3.6 | GO:0031626 | beta-endorphin binding(GO:0031626) |
1.2 | 5.9 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
1.2 | 4.6 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
1.1 | 15.7 | GO:0005536 | glucose binding(GO:0005536) |
1.1 | 3.4 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
1.1 | 48.9 | GO:0003777 | microtubule motor activity(GO:0003777) |
1.1 | 57.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
1.1 | 3.2 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
1.1 | 210.3 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
1.0 | 20.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
1.0 | 5.2 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
1.0 | 10.3 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
1.0 | 5.1 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
1.0 | 8.2 | GO:0030882 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
1.0 | 9.2 | GO:0008199 | ferric iron binding(GO:0008199) |
1.0 | 13.2 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
1.0 | 210.8 | GO:0003924 | GTPase activity(GO:0003924) |
1.0 | 3.9 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
1.0 | 31.9 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
1.0 | 11.4 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.9 | 36.7 | GO:0009055 | electron carrier activity(GO:0009055) |
0.9 | 20.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.9 | 8.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.9 | 13.6 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.9 | 2.6 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.9 | 7.0 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.8 | 3.3 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.8 | 29.7 | GO:0042805 | actinin binding(GO:0042805) |
0.8 | 1.6 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.8 | 2.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.8 | 17.3 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.8 | 1.6 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.8 | 2.3 | GO:0003988 | acetyl-CoA C-acetyltransferase activity(GO:0003985) acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.7 | 6.7 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.7 | 10.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.7 | 4.4 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.7 | 11.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.7 | 93.4 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.7 | 4.2 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.7 | 9.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.7 | 3.9 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.6 | 4.4 | GO:0033691 | sialic acid binding(GO:0033691) |
0.6 | 3.1 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.6 | 1.9 | GO:0070402 | NADPH binding(GO:0070402) |
0.6 | 4.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.6 | 40.5 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.6 | 1.8 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.6 | 2.3 | GO:0032190 | acrosin binding(GO:0032190) |
0.6 | 1.7 | GO:0016524 | latrotoxin receptor activity(GO:0016524) |
0.6 | 7.9 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.6 | 2.2 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.5 | 3.3 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.5 | 2.7 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.5 | 23.9 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.5 | 2.6 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.5 | 6.6 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.5 | 1.5 | GO:0019863 | IgE binding(GO:0019863) |
0.5 | 5.4 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.5 | 9.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.5 | 24.5 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.5 | 1.9 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
0.5 | 3.7 | GO:0015232 | heme transporter activity(GO:0015232) |
0.5 | 2.3 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.5 | 1.4 | GO:0031208 | POZ domain binding(GO:0031208) |
0.5 | 4.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 6.6 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.4 | 1.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.4 | 2.1 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.4 | 2.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.4 | 102.0 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.4 | 1.6 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.4 | 2.8 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.4 | 18.0 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.4 | 3.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.4 | 6.9 | GO:0051287 | NAD binding(GO:0051287) |
0.4 | 14.2 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.4 | 1.9 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.4 | 1.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.4 | 3.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.4 | 2.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.3 | 1.0 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.3 | 126.2 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.3 | 4.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 2.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.3 | 7.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 1.0 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
0.3 | 1.6 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.3 | 1.6 | GO:0042979 | ornithine decarboxylase inhibitor activity(GO:0008073) ornithine decarboxylase regulator activity(GO:0042979) |
0.3 | 2.8 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.3 | 0.9 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.3 | 0.9 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 1.2 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.3 | 0.9 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 3.9 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.3 | 4.9 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.3 | 1.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.2 | 1.0 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.2 | 0.7 | GO:0046577 | long-chain-alcohol oxidase activity(GO:0046577) |
0.2 | 0.9 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.2 | 0.7 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.2 | 0.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.2 | 1.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 0.7 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.2 | 5.5 | GO:0019956 | chemokine binding(GO:0019956) |
0.2 | 2.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.2 | 1.5 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.2 | 0.9 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
0.2 | 1.1 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.2 | 10.3 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.2 | 1.0 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 0.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 2.1 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 1.6 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 2.6 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 8.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.7 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 2.2 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.4 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.5 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.1 | 0.5 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 0.5 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 0.2 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.0 | 1.6 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.9 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.3 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.8 | 654.9 | PID BARD1 PATHWAY | BARD1 signaling events |
11.8 | 317.8 | PID ARF 3PATHWAY | Arf1 pathway |
11.7 | 46.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
11.3 | 124.8 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
10.2 | 325.6 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
10.1 | 888.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
9.8 | 137.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
9.5 | 492.3 | PID ATR PATHWAY | ATR signaling pathway |
9.3 | 167.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
8.4 | 377.6 | PID AURORA A PATHWAY | Aurora A signaling |
7.9 | 276.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
7.7 | 199.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
7.7 | 581.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
7.2 | 171.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
7.1 | 335.1 | PID ALK1 PATHWAY | ALK1 signaling events |
7.0 | 267.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
6.9 | 510.2 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
6.8 | 857.1 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
6.6 | 26.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
6.3 | 177.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
6.3 | 177.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
6.2 | 271.6 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
5.2 | 352.7 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
5.2 | 207.0 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
5.1 | 199.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
5.1 | 442.8 | PID E2F PATHWAY | E2F transcription factor network |
4.8 | 100.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
4.3 | 99.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
4.1 | 150.4 | PID PLK1 PATHWAY | PLK1 signaling events |
3.8 | 174.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
3.8 | 135.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
3.6 | 39.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
3.6 | 132.2 | PID AURORA B PATHWAY | Aurora B signaling |
3.5 | 14.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
3.2 | 6.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
3.1 | 137.1 | PID P53 REGULATION PATHWAY | p53 pathway |
3.1 | 120.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
3.0 | 119.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
2.9 | 37.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
2.8 | 50.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
2.8 | 22.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
2.7 | 16.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
2.7 | 13.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
2.6 | 25.6 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
2.5 | 66.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
2.5 | 55.6 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
2.5 | 358.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
2.5 | 66.6 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
2.4 | 16.8 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
2.3 | 22.7 | PID FOXO PATHWAY | FoxO family signaling |
2.1 | 10.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
2.1 | 46.6 | PID INSULIN PATHWAY | Insulin Pathway |
2.1 | 8.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
2.0 | 23.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.9 | 101.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
1.9 | 24.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.8 | 48.8 | PID IFNG PATHWAY | IFN-gamma pathway |
1.8 | 14.5 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
1.8 | 5.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
1.7 | 36.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
1.7 | 43.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
1.7 | 20.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
1.6 | 122.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
1.6 | 62.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
1.6 | 16.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.6 | 12.8 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
1.6 | 31.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
1.5 | 44.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
1.5 | 56.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
1.5 | 55.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
1.5 | 16.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
1.4 | 44.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
1.4 | 116.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
1.3 | 10.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
1.2 | 8.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
1.2 | 34.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
1.2 | 28.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
1.1 | 15.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
1.1 | 47.0 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
1.1 | 23.5 | PID S1P S1P1 PATHWAY | S1P1 pathway |
1.1 | 10.7 | PID BCR 5PATHWAY | BCR signaling pathway |
1.0 | 4.1 | PID MYC PATHWAY | C-MYC pathway |
1.0 | 54.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.9 | 41.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.9 | 6.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.9 | 28.1 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.8 | 18.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.8 | 47.1 | PID P73PATHWAY | p73 transcription factor network |
0.8 | 45.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.8 | 7.0 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.8 | 3.9 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.7 | 29.5 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.7 | 48.3 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.7 | 29.9 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.7 | 13.9 | PID RHOA PATHWAY | RhoA signaling pathway |
0.7 | 3.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.7 | 12.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.7 | 11.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.7 | 15.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.7 | 11.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.6 | 12.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.6 | 23.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.6 | 30.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.6 | 13.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.6 | 6.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.5 | 6.9 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.5 | 17.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.5 | 1.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.5 | 20.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.4 | 12.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.4 | 5.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.4 | 2.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.3 | 6.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.2 | 4.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 2.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 3.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.7 | PID ATM PATHWAY | ATM pathway |
0.1 | 1.0 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
34.4 | 2373.8 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
32.5 | 487.1 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
30.3 | 333.0 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
26.7 | 1972.9 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
26.5 | 291.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
24.9 | 572.1 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
24.8 | 446.8 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
21.0 | 2731.5 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
21.0 | 21.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
20.0 | 379.6 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
19.4 | 116.6 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
19.3 | 405.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
19.2 | 38.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
18.0 | 844.0 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
17.5 | 525.0 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
17.4 | 538.8 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
15.9 | 539.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
15.3 | 230.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
14.7 | 1691.7 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
14.4 | 346.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
14.0 | 42.0 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
13.8 | 220.8 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
13.6 | 189.9 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
13.3 | 437.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
13.0 | 143.3 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
12.9 | 129.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
12.9 | 218.8 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
12.7 | 228.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
11.9 | 381.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
11.9 | 190.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
11.8 | 212.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
11.6 | 46.6 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
11.2 | 168.0 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
11.1 | 255.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
10.9 | 98.0 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
10.4 | 585.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
10.4 | 145.5 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
9.9 | 98.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
9.7 | 448.2 | REACTOME TRANSLATION | Genes involved in Translation |
9.6 | 57.4 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
9.5 | 391.4 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
9.4 | 159.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
9.4 | 786.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
9.2 | 220.5 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
9.0 | 261.5 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
8.3 | 141.4 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
8.1 | 113.8 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
8.1 | 113.2 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
8.0 | 208.6 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
8.0 | 424.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
8.0 | 31.9 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
7.9 | 151.0 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
7.9 | 424.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
7.6 | 182.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
7.6 | 211.7 | REACTOME KINESINS | Genes involved in Kinesins |
7.4 | 282.9 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
7.4 | 273.9 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
7.3 | 29.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
6.9 | 13.7 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
6.9 | 123.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
6.7 | 73.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
6.7 | 214.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
6.4 | 216.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
6.2 | 174.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
6.1 | 79.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
6.1 | 121.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
5.9 | 356.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
5.9 | 892.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
5.9 | 47.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
5.8 | 190.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
5.8 | 5.8 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
5.7 | 215.0 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
5.6 | 128.6 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
5.6 | 16.7 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
5.5 | 164.6 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
5.4 | 81.6 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
5.4 | 108.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
5.4 | 59.1 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
5.4 | 101.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
5.1 | 205.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
5.1 | 46.1 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
5.1 | 76.6 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
5.0 | 25.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
4.9 | 97.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
4.8 | 101.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
4.8 | 67.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
4.7 | 145.2 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
4.4 | 13.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
4.2 | 71.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
4.2 | 50.2 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
4.2 | 29.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
4.1 | 49.4 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
4.0 | 84.9 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
4.0 | 24.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
4.0 | 71.6 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
3.8 | 172.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
3.8 | 60.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
3.8 | 76.0 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
3.7 | 85.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
3.6 | 51.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
3.6 | 119.0 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
3.5 | 21.0 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
3.5 | 97.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
3.5 | 45.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
3.5 | 107.3 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
3.5 | 34.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
3.5 | 10.4 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
3.4 | 135.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
3.2 | 25.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
3.2 | 25.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
3.2 | 113.5 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
3.1 | 367.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
3.1 | 15.3 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
3.0 | 3.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
2.9 | 240.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
2.9 | 11.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
2.8 | 85.5 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
2.7 | 16.4 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
2.7 | 51.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
2.7 | 10.7 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
2.7 | 21.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
2.5 | 22.8 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
2.5 | 49.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
2.5 | 9.8 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
2.5 | 44.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
2.4 | 22.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
2.4 | 47.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
2.3 | 112.4 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
2.3 | 2.3 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
2.2 | 186.6 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
2.0 | 28.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
2.0 | 6.0 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
2.0 | 29.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
1.9 | 42.4 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
1.9 | 94.4 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
1.9 | 36.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
1.9 | 13.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
1.8 | 99.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.8 | 78.0 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
1.7 | 85.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
1.5 | 1.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.4 | 144.9 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
1.4 | 8.2 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
1.4 | 37.9 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
1.3 | 28.8 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
1.2 | 17.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
1.1 | 18.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
1.1 | 13.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
1.1 | 4.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
1.0 | 7.1 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
1.0 | 31.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
1.0 | 25.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
1.0 | 25.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
1.0 | 22.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.9 | 13.2 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.9 | 3.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.8 | 18.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.8 | 33.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.8 | 34.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.8 | 0.8 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.7 | 20.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.7 | 48.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.7 | 14.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.7 | 7.9 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.7 | 15.7 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.6 | 25.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.6 | 17.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.6 | 3.6 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.6 | 15.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.4 | 45.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.4 | 2.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.4 | 4.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.4 | 1.9 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.3 | 6.0 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.3 | 45.4 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
0.2 | 3.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 4.0 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.2 | 1.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 1.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.3 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 9.1 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 1.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 2.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 1.1 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 1.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 1.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |